News & Analysis on Clinical Trial Services & Contract Research And Development
Filtration and purification specialist Pall has reported a 12.5 per cent hike in first-quarter sales to $374 million (€310m), with life sciences putting in a strong showing, up 15.5 per cent to $152 million.
A new report claims that there is little future for small- to medium-sized research-based pharmaceutical companies over the next 12 years, as they will simply not have the R&D muscle needed to survive, says a new report from Decision Resources (DR).
Aerosol delivery specialist Inyx has entered into an agreement with a European partner that will see the company sign a partner for its dry powder inhaler (DPI) technologies for the first time.
UK encapsulation company BioProgress yesterday unveiled plans to raise £6.6 million (€9.4m) through a placement of shares in order to build a new pharmaceutical production plant.